Twenty-five of these (46%) showed a high expression (3+ and 2+) of HMGA2, and 15 (27%) tumours showed low expression (1+), and 15 (27%) tumours were negative immunoreactions (Table 2). Here, HMGA2 is linked to neoplasm.